Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for postgraduate education in haematology.
et al., 2022, Humanistic burden of problem joints for children and adults with haemophilia., Haemophilia
et al., 2022, The effect of TRV027 on coagulation in COVID 19: A pilot randomized, placebo-controlled controlled trial, British Journal of Clinical Pharmacology, ISSN:0306-5251
et al., 2022, Autoimmune disease and COVID-19- a multicentre observational study in the United Kingdom, Rheumatology, Vol:61, ISSN:1462-0324, Pages:4643-4655
et al., 2022, Cerebral vein thrombosis after ChAdOx1 nCov-19 vaccination: Long-term outcome of four patients, Research and Practice in Thrombosis and Haemostasis, Vol:6
et al., 2022, Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome - Single Centre Observational Study in the United Kingdom, Seminars in Thrombosis and Hemostasis, ISSN:0094-6176